U-Blot® Research Grade OzekibartCat. No. WA3316Request quote
Size: 50ug/100ug
Overview
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade OzekibartCat. No. WA3316U-Blot® Research Grade OzanezumabCat. No. WA3315Request quote
Size: 50ug/100ug
U-Blot® Research Grade OxelumabCat. No. WA3314Request quote
Size: 50ug/100ug
U-Blot® Research Grade oturkibartCat. No. WA3313Request quote
Size: 50ug/100ug
U-Blot® Research Grade OtlertuzumabCat. No. WA3312Request quote
Size: 50ug/100ug
U-Blot® Research Grade OtilimabCat. No. WA3311Request quote
Size: 50ug/100ug
U-Blot® Research Grade OtelixizumabCat. No. WA3310Request quote
Size: 50ug/100ug
U-Blot® Research Grade OsocimabCat. No. WA3309Request quote
Size: 50ug/100ug
U-Blot® Research Grade OsemitamabCat. No. WA3308Request quote
Size: 50ug/100ug
U-Blot® Research Grade OrticumabCat. No. WA3307Request quote
Size: 50ug/100ug
U-Blot® Research Grade OrmutivimabCat. No. WA3306Request quote
Size: 50ug/100ug
U-Blot® Research Grade OrilanolimabCat. No. WA3305Request quote
Size: 50ug/100ug
REQUEST A QUOTE
EMAILinfo@mail.ucallm.com
PHONE+(1)-866-986-9598
ONLINE FORMOnline Quote Submission
X+(1)-866-986-9598